Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...

In a clinical setting, the acquisition of certain medical image modality is often unavailable due to various considerations such as cost, radiation, etc. Therefore, unpaired cross-modality translation ...

The pathophysiology of heart failure is complex, but mitochondrial dysfunction is an emerging therapeutic target to improve cardiac function. In this Consensus Statement, insights into the ...

Anderson Fabry disease is a rare genetic disease characterized by a defect in a X-Linked gene, the alpha galactosidase. Due to the sexual chromosome localization of the gene, men patients present a ...

CSL shares are down nearly 20% over 5 years. Is the stock undervalued today? Let's see what JP Morgan and other experts think.

Amycretin — a novel experimental molecular targeting both the glucagon-like peptide 1 (GLP-1) and the amylin receptor — has shown promise for weight management in early-phase clinical trials ...

Rhizoctonia solani Secretes RsCAP3 to Target Nb14–3–3b, Interfering with Hormone-Mediated Resistance in Nicotiana benthamiana ...

The main hormones secreted by the endocrine gland in the pancreas are insulin and glucagon, which regulate the level of glucose in the blood, and somatostatin, which prevents the release of insulin ...

One of the incretin hormones is hot among those who are pursuing weight loss for healthy living. The GLP-1 (glucagon-like peptide 1) helps with weight loss and maintains blood sugar levels by ...

This paper proposes an intraoperative organ motion tracking method based on the fusion of inertial navigation and electromagnetic navigation., which can directly measure the target organ's movement ...